Kestra Advisory Services, LLC Seres Therapeutics, Inc. Transaction History
Kestra Advisory Services, LLC
- $19.6 Billion
- Q1 2025
A detailed history of Kestra Advisory Services, LLC transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 38,471 shares of MCRB stock, worth $593,992. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,471
Previous 38,471
-0.0%
Holding current value
$593,992
Previous $31,000
16.13%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding MCRB
# of Institutions
38Shares Held
29MCall Options Held
103KPut Options Held
53K-
Flagship Pioneering Inc. Cambridge, MA23.1MShares$357 Million6.86% of portfolio
-
Black Rock Inc. New York, NY1.76MShares$27.2 Million0.0% of portfolio
-
Lion Point Capital, LP New York, NY341KShares$5.26 Million2.45% of portfolio
-
Tang Capital Management LLC San Diego, CA204KShares$3.15 Million0.01% of portfolio
-
Morgan Stanley New York, NY150KShares$2.31 Million0.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $1.92B
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...